273 results on '"Novartis Pharma AG -- Reports"'
Search Results
2. Reports from Novartis Pharmaceuticals AG Add New Study Findings to Research in Inflammatory Bowel Disease (Adenosine-mediated immune responses in inflammatory bowel disease)
3. New Findings in Chronic Myeloid Leukemia Described from University Clinic (Asciminib In Newly Diagnosed Chronic Myeloid Leukemia)
4. Food Allergy Therapeutics Market Size in the 7Mm was ~USD 1,648 Million in 2023, is expected to grow by 2034, and estimates DelveInsight
5. FORM 8-K: Olema Pharmaceuticals, Inc. Files Current Report (Dec 02, 2024)
6. Paroxysmal Nocturnal Hemoglobinuria Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers
7. Findings from Novartis Pharmaceuticals AG in Heart Failure Reported (Centrally adjudicated vs. investigator-reported outcomes in randomized heart failure trials)
8. Refractory Multiple Myeloma Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers
9. Rheumatoid Arthritis Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers
10. Neuroendocrine Tumors Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers
11. FORM 8-K: Voyager Therapeutics, Inc. Files Current Report (Sep 05, 2024)
12. Multiple Sclerosis Pipeline Drugs 2024 | TG Therapeutics, Immunic, Atara Biotherapeutics, ANOKION, ImStem Biotechnology, Merck Serono, CinnaGen, Immune Response BioPharma, Inc., Clene Nanomedicine, Ge
13. Recent Findings from University of Genoa Provides New Insights into Breast Cancer (Impact of Anti-her2 Therapy Alone and With Weekly Paclitaxel On the Ovarian Reserve of Young Women With Her2-positive Breast Cancer)
14. Food Allergy Market Size was USD 1,648 Million in 2023 and Expected to Grow by 2034, estimates DelveInsight
15. FORM 8-K: ARVINAS, INC. Files Current Report (May 30, 2024)
16. Thyroid Cancer Pipeline Insights Report 2024
17. Chronic Myelomonocytic Leukaemia Pipeline Outlook Report 2024
18. Icahn School of Medicine at Mount Sinai Reports Findings in Psoriasis (Deep Resolution of Clinical, Cellular and Transcriptomic Inflammatory Markers of Psoriasis Over 52 Weeks of Interleukin-17a Inhibition By Secukinumab)
19. Reports Summarize Multiple Sclerosis Study Results from University Catolica San Antonio (Consensus Statement of the Spanish Society of Neurology On the Treatment of Multiple Sclerosis and Holistic Patient Management In 2023)
20. Studies from King Fahad Medical City Have Provided New Data on Psoriatic Arthritis (Effectiveness of secukinumab in patients with psoriasis and psoriatic arthritis in a Saudi real-world setting)
21. Research from Novartis India Ltd. Broadens Understanding of Type 2 Diabetes (Health and Productivity Benefits with Early Intensified Treatment in Patients with Type 2 Diabetes: Results from Korea)
22. Non-Alcoholic Fatty Liver Disease Pipeline, FDA Approvals, Research and Developments, Future Perspectives, and Companies (Updated)
23. Autoimmune Hepatitis Pipeline, Clinical Trials Studies, Emerging Drugs, Mergers and Acquisition, Licensing, Agreements & Collaborations, and Latest News 2023 (Updated)
24. FORM 8-K: BeiGene, Ltd. Files Current Report (Sep 19, 2023)
25. Researchers from University of California San Francisco (UCSF) Report Details of New Studies and Findings in the Area of Prostate Cancer (Single-dose 177lu-psma-617 Followed By Maintenance Pembrolizumab In Patients With Metastatic Castration- ...)
26. Novartis Pharmaceuticals AG Reports Findings in Myelodysplastic Syndromes (Experiences and Support Needs of Caregivers of Patients with Higher-Risk Myelodysplastic Syndrome via Online Bulletin Board in the USA, Canada and UK)
27. New Findings Reported from RTI Health Solutions Describe Advances in Asthma (Psychometric evaluation of an electronic Asthma Symptom Diary for young children)
28. Reports from Novartis Pharmaceuticals AG Highlight Recent Findings in Obesity, Fitness and Wellness (Rescoss: a Flexible Quantum Chemistry Workflow Identifying Relevant Solution Conformers of Drug-like Molecules)
29. Research and Markets Adds Report: Food Allergy
30. FORM 8-K: BeiGene, Ltd. Files Current Report (Jul 11, 2023)
31. Study Findings on Alzheimer Disease Are Outlined in Reports from Novartis Pharmaceuticals AG [Discovery of Umibecestat (Cnp520): a Potent, Selective, and Efficacious Beta-secretase (Bace1) Inhibitor for the Prevention of Alzheimer's Disease]
32. Novartis Pharmaceuticals AG Researchers Release New Study Findings on Pharmaceutics (Tablet formulation development focusing on the functional behaviour of water uptake and swelling)
33. Regensburg University Hospital Reports Findings in Multiple Sclerosis (Tolerability of subcutaneous ofatumumab with long-term exposure in relapsing multiple sclerosis)
34. New Findings on Age-Related Macular Degeneration from Rush University Medical Center Summarized [Y One-year Brolucizumab Outcomes In Neovascular Age-related Macular Degeneration From a Large United States Cohort In the Iris ® Registry]
35. Studies from Novartis Pharmaceuticals AG Describe New Findings in Pharmaceutical Research (Single-crystal Drying: Development of a Continuous Drying Prototype To Optimize Particle Flow and Residence Time Distribution)
36. Researchers' Work from Novartis Pharmaceuticals AG Focuses on Personalized Medicine (Using Knockoffs for Controlled Predictive Biomarker Identification)
37. Vasculitis Pipeline 2023: Robust Pipeline With 20 + Key Pharma Companies Actively Working in the domain, observes DelveInsight | CytoDyn, ChemoCentryx, Roche, GlaxoSmithKline, Vifor Pharma
38. FORM 8-K: SomaLogic, Inc. Files Current Report (Jan 10, 2023)
39. FORM 8-K: IONIS PHARMACEUTICALS, INC. Files Current Report (Jan 09, 2023)
40. Novartis Pharmaceuticals AG Researchers Describe Recent Advances in Sjogren's Syndrome (Development and content validity assessment of the Dry Eye Disease Questionnaire in patients with dry eye disease, meibomian gland dysfunction, and ...)
41. Stanford University Reports Findings in Mucoproteins (The Role of Membrane-tethered Mucins In Axial Epithelial Adhesion In Controlled Normal Stress Environments)
42. Recent Findings from University of Cincinnati Highlight Research in Urticaria (Why a Complete Response Is the Treatment Aim in Chronic Spontaneous Urticaria)
43. New Business Study Findings Reported from Novartis Pharmaceuticals AG (DMC reports in the 21st century: towards better tools for decision-making)
44. Propulsion of Nonalcoholic Steatohepatitis Pipeline as Novel and Extensive 150+ Therapies Likely to Enter in the Treatment Domain | DelveInsight
45. New Data from Novartis Pharmaceuticals K.K. Illuminate Findings in Soft Tissue Sarcomas (Postmarketing observational study of pazopanib in patients with metastatic soft tissue sarcoma in Japan)
46. Studies from Novartis Pharmaceuticals AG Add New Findings in the Area of Organic Research (A General Kilogram Scale Protocol for Suzuki-miyaura Cross-coupling In Water With Tpgs-750-m Surfactant)
47. New Findings Reported from Novartis Pharmaceuticals AG Describe Advances in Steroid Receptors [Synthesis Development of the Selective Estrogen Receptor Degrader (Serd) Lsz102 From a Suzuki Coupling To a C-h Activation Strategy]
48. New Findings from Novartis Pharmaceuticals AG Yields New Data on Clinical Pharmacology (Reporting rates of adverse reactions to specialty care medicines exhibit a direct positive correlation with patient exposure: a lack of evidence for the ...)
49. New Heart Failure Study Findings Have Been Reported by Investigators at Georg-August-University (Serelaxin Alleviates Cardiac Fibrosis Through Inhibiting Endothelial-to-mesenchymal Transition Via Rxfp1)
50. Researchers from Novartis Pharmaceuticals Report on Findings in Pharmaceutical Research (Predictive Model-Based Process Start-Up in Pharmaceutical Continuous Granulation and Drying)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.